Cellular Physiology and Biochemistry · 2018 · 100 citations · 28 references
Life SciencesMolecular BiologyPharmacologyCell SignalingInflammationSignal TransductionCartilage MetabolismCytokine BiologyInflammation PharmacologyInflammatory MediatorsInflammatory SignalingOsteoarthritisAnti-inflammatory TherapeuticsCartilage Breakdown PathophysiologyCartilage Degradation MechanismsInflammatory Mediator PathwaysInflammatory Mediator PharmacologyInflammatory Mediators In CartilageMetabolic Regulation Of InflammationSystemic Inflammation Markers
BACKGROUND/AIMS: Osteoarthritis (OA) is a joint degenerative biomechanical disorder involving immunity, metabolic alterations, inflammation, and cartilage degradation, where chondrocytes play a pivotal role. OA has not effective pharmacological treatments and new therapeutic targets are needed. Adipokines contribute to the low-grade systemic inflammation in OA. Here, we explored novel molecular mechanisms of sodium butyrate (BuNa) in modulating inflammation and chemotaxis in chondrocytes, demonstrating the direct involvement of its G protein-coupled receptor (GPR)-43. METHODS: ATDC5 murine chondrocytes were stimulated with interleukin (IL)-1β, in the presence or not of BuNa, for 24 h. RT-PCR and Western blot analysis was performed to evaluate the expression of inflammatory mediators and structural proteins. RESULTS: Butyrate reduced the expression of canonic pro-inflammatory mediators (Nos2, COX-2, IL-6), pro-inflammatory adipokines (lipocalin-2 and nesfatin-1) and adhesion molecule (VCAM-1 and ICAM-1) in IL-1β-stimulated chondrocytes, inhibiting several inflammatory signalling pathways (NFκB, MAPKinase, AMPK-α, PI3K/Akt). Butyrate also reduced metalloproteinase production and limited the loss of type II collagen in IL-1β-inflamed chondrocytes. The chemoattractant effect of butyrate, after different inflammatory challenges, was revealed by increased annexin (AnxA)1 levels and chemokines expression. The chemoattractant and anti-inflammatory activities of butyrate were completely blunted by GPR43 silencing using RNA interference. CONCLUSION: Taken together, our data suggest the potential application of sodium butyrate as a novel candidate in a multi-target approach for the treatment of chondrocyte inflammation and cartilage degenerative process.
28
SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor
Marco Aurélio Ramirez Vinolo, Gail Ferguson, Suhasini Kulkarni et al. · PLoS ONE · 2011 · 287 citations · Full text
Giuseppina Mattace Raso, Raffaele Simeoli, Roberto Russo et al. · PLoS ONE · 2013 · 200 citations · Full text